Clinical Trials

MainTitle

Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients

The recruitment status of this study is unknown.

Verified January 2009 by Rajavithi Hospital

Sponsor
Rajavithi Hospital


Information provided by (Responsible Party)
Rajavithi Hospital
ClinicalTrials.gov Identifier
NCT01546376

First received: March 2, 2012
Last updated: March 6, 2012
Last Verified: January 2009
History of Changes
Purpose

Purpose

Objectives: To study immunostatus (CD4) and HIV viral load in HIV-cancer patients before RT and last weeks of RT .

Condition Intervention
To Study Immunostatus of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT
To Study HIV Viral Load of HIV-cancer Patients Who Recived RT Befor RT and Last Week of RT

Radiation : Radiation therapy
Other : Venepuncture

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients

Further study details as provided by Rajavithi Hospital:

Estimated Enrollment: 100
Study Start Date: August 2009

Arms Assigned Interventions
HIV-cancer patients who recived RT

Radiation: Radiation therapy

External photon beam radiation therapy dosage 4000-7000 CGy

Other: Venepuncture

Venepuncture for CD4 and viral load count at Week 0, Last week of Radiation, and 12, 24 Week follow up

Eligibility

Eligibility

Ages Eligible for Study: 18 Years to 65 Years  
Sexes Eligible for Study: All  
Accepts Healthy Volunteers: Yes  
Sampling Method: Non-Probability Sample  

Study Population

HIV positive cancer patients Curative RT treatment

Criteria

Inclusion Criteria:

  • Age 18-65 years
  • HIV positive cancer patients
  • Photon beam RT, conventional fraction >= 4000 cgy in 4 weeks


Exclusion Criteria:
  • CD4 count < 200 cell/ml and not received anti retro viral

contacts and locations

Contacts and Locations

Choosing to participate in a study is an important personal decision.Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01546376

Contacts

Contact:   Pathomphorn Siraprapasiri, MD 66-89-6662960 spathomphorm@gmail.com

Locations

Thailand
Rajavithi Hospital Recruiting
Bangkok, Thailand, 10400
Contact: Pathomphorn Siraprapasiri, MD    66-89-6662960    spathomphorn@gmail.com

Sponsors and Collaborators

Rajavithi Hospital
More Information

More Information


Responsible Party: Rajavithi Hospital  
ClinicalTrials.gov Identifier: NCT01546376   History of Changes  
Other Study ID Numbers: THAIHIV001  
Study First Received: March 2, 2012  
Last Updated: March 6, 2012  

ClinicalTrials.gov processed this data on December 12, 2017
This information is provided by ClinicalTrials.gov.